Article (Scientific journals)
A Belgian multicentre study of fluvoxamine in depressive outpatients
Brasseur, R.; van Moffaert, M.; Mesotten, F. et al.
1985In Acta Psychiatrica Belgica, 85 (5), p. 636-643
Peer Reviewed verified by ORBi
 

Files


Full Text
A Belgian multicentre study of fluvoxamine in depressive outpatients.pdf
Publisher postprint (3.46 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Adult; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Female; Fluvoxamine; Humans; Male; Oximes; Psychiatric Status Rating Scales
Abstract :
[en] Fluvoxamine, a new antidepressant that specifically inhibits serotonin reuptake, was studied in 272 outpatients in a six-week multicentre trial in Belgium. On the Hamilton Depression Scale, the mean score dropped from 25.2 to 8 after six weeks (p<0.00001). The Clinical Global Impression scores showed similar evolution. Fluvoxamine is a real antidepressant with a marked effect on mood. Its effective dosage is 100 mg to 200 mg/day. Its tolerance, notably at the cardiovascular level, is excellent.
Disciplines :
Treatment & clinical psychology
Author, co-author :
Brasseur, R.
van Moffaert, M.;  Department of Psychiatry, Saint-Ann Hospital, Brussels, Belgium
Mesotten, F.;  Department of Psychiatry, Saint-Ann Hospital, Brussels, Belgium
ANSSEAU, Marc ;  Université de Liège - ULg
Uytdenhoef, P.
Bartholome, F.
Language :
English
Title :
A Belgian multicentre study of fluvoxamine in depressive outpatients
Publication date :
1985
Journal title :
Acta Psychiatrica Belgica
ISSN :
0300-8967
Publisher :
Acta Medica Belgica, Belgium
Volume :
85
Issue :
5
Pages :
636-643
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 08 May 2021

Statistics


Number of views
54 (1 by ULiège)
Number of downloads
11 (1 by ULiège)

Scopus citations®
 
2
Scopus citations®
without self-citations
2

Bibliography


Similar publications



Contact ORBi